DECIPHERA PHARMACEUTICALS IN's ticker is DCPH and the CUSIP is 24344T101. A total of 144 filers reported holding DECIPHERA PHARMACEUTICALS IN in Q2 2023. The put-call ratio across all filers is 0.90 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $922,518 | -4.5% | 72,525 | +5.7% | 0.00% | – |
| Q2 2023 | $966,001 | -53.4% | 68,608 | -48.8% | 0.00% | – |
| Q1 2023 | $2,071,119 | -2.2% | 134,053 | +3.8% | 0.00% | – |
| Q4 2022 | $2,117,342 | -34.2% | 129,185 | -25.8% | 0.00% | – |
| Q3 2022 | $3,219,000 | +67.8% | 174,003 | +19.3% | 0.00% | – |
| Q2 2022 | $1,918,000 | -18.9% | 145,852 | -42.9% | 0.00% | – |
| Q1 2022 | $2,365,000 | -85.1% | 255,216 | -84.2% | 0.00% | – |
| Q4 2021 | $15,820,000 | +226.1% | 1,619,354 | +1033.9% | 0.00% | – |
| Q3 2021 | $4,852,000 | -21.1% | 142,815 | -15.0% | 0.00% | – |
| Q2 2021 | $6,150,000 | +17.5% | 167,999 | +43.9% | 0.00% | – |
| Q1 2021 | $5,234,000 | -78.9% | 116,730 | -73.1% | 0.00% | -100.0% |
| Q4 2020 | $24,794,000 | +89.7% | 434,454 | +70.5% | 0.00% | -66.7% |
| Q3 2020 | $13,069,000 | -1.2% | 254,777 | +15.0% | 0.00% | 0.0% |
| Q2 2020 | $13,231,000 | +107.5% | 221,545 | +43.0% | 0.00% | +50.0% |
| Q1 2020 | $6,377,000 | -71.7% | 154,886 | -57.2% | 0.00% | -66.7% |
| Q4 2019 | $22,535,000 | +162.3% | 362,051 | +43.0% | 0.01% | +100.0% |
| Q3 2019 | $8,591,000 | +135.2% | 253,117 | +56.3% | 0.00% | – |
| Q2 2019 | $3,652,000 | +1402.9% | 161,892 | +1295.6% | 0.00% | – |
| Q4 2018 | $243,000 | -23.6% | 11,600 | +41.5% | 0.00% | – |
| Q3 2018 | $318,000 | -10.2% | 8,200 | -8.9% | 0.00% | – |
| Q2 2018 | $354,000 | – | 9,001 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 1,209,571 | $72,236,000 | 20.73% |
| SV Health Investors, LLC | 449,951 | $26,871,000 | 18.64% |
| Redmile Group, LLC | 4,978,941 | $297,342,000 | 5.49% |
| Sunesis Advisors, LLC | 96,299 | $5,751,000 | 5.29% |
| Eversept Partners, LP | 418,652 | $25,001,897 | 3.43% |
| Opaleye Management Inc. | 222,000 | $13,081,000 | 2.64% |
| Avoro Capital Advisors LLC | 1,860,000 | $111,079,000 | 2.20% |
| SPHERA FUNDS MANAGEMENT LTD. | 282,965 | $16,899,000 | 1.59% |
| SECTORAL ASSET MANAGEMENT INC | 224,359 | $13,399,000 | 1.23% |
| Artal Group S.A. | 650,000 | $38,818,000 | 1.09% |